Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2245 (LINC02245) is an lncRNA gene located on human chromosome 2 (GRCh38: 64,901,840-65,056,233, reverse strand). It produces multiple transcript variants, but none are protein-encoding; all function as lncRNAs. Common aliases include lnc-SERTAD2-3 and AC007386.2. There is no demonstrated biological function, disease association, drug interaction, or mechanism of action for LINC02245 at present. It remains a non-protein-coding gene with unknown biological significance and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2245 (LINC02245).